Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease.

MLA

Jiang, Yan, et al. “Current Perspectives on Mesenchymal Stem Cells as a Potential Therapeutic Strategy for Non-Alcoholic Fatty Liver Disease.” World Journal of Stem Cells, vol. 16, no. 7, July 2024, pp. 760–72. EBSCOhost, https://doi.org/10.4252/wjsc.v16.i7.760.

APA

Jiang, Y., Yusoff, N. M., Du, J., Moses, E. J., & Lin, J.-T. (2024). Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease. World Journal of Stem Cells, 16(7), 760–772. https://doi.org/10.4252/wjsc.v16.i7.760

Chicago

Jiang, Yan, Narazah Mohd Yusoff, Jiang Du, Emmanuel Jairaj Moses, and Jun-Tang Lin. 2024. “Current Perspectives on Mesenchymal Stem Cells as a Potential Therapeutic Strategy for Non-Alcoholic Fatty Liver Disease.” World Journal of Stem Cells 16 (7): 760–72. doi:10.4252/wjsc.v16.i7.760.